A study by the Bernard Malissen (CIML CNRS, Inserm, AMU Marseille), M. Gstaiger (IMSB) and R. Aebersold (IMSB) groups which appeared in Cell Reports, identifies using proteomics and mouse models molecular mechanisms that might account for some of the failures observed during immunotherapy... CIML Headline
